Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Porcine reproductive and respiratory virus 2 infection of the fetus results in multi-organ cell cycle suppression. | Vet Res | 2022 | 35189966 | PubTator, text mining | PubMed |
| Mechanistic modelling of enzyme-restoration effects of new recombinant liver-targeted proteins in acute intermittent porphyria. | Br J Pharmacol | 2022 | 35170015 | PubTator, text mining | PubMed |
A boy with blistering of sun-exposed skin and finger shortening: the first case of Variegate Porphyria with a novel mutation in protoporphyrinogen oxidase (PPOX) gene in Iran: a case report and literature review. | Ital J Pediatr | 2022 | 35164799 | PubTator, text mining | PubMed |
| Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity. | Int J Mol Sci | 2022 | 35163824 | PubTator, text mining | PubMed |
| Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins. | Int J Mol Sci | 2022 | 35163473 | PubTator, text mining | PubMed |
| Regulation of Opsin Gene Expression by DNA Methylation and Histone Acetylation. | Int J Mol Sci | 2022 | 35163334 | PubTator, text mining | PubMed |
| Indomethacin and Diclofenac Hybrids with Oleanolic Acid Oximes Modulate Key Signaling Pathways in Pancreatic Cancer Cells. | Int J Mol Sci | 2022 | 35163154 | PubTator, text mining | PubMed |
| Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. | Cancers (Basel) | 2022 | 35158943 | PubTator, text mining | PubMed |
| Differences in nanoscale organization of regulatory active and inactive human chromatin. | Biophys J | 2022 | 35150617 | PubTator, text mining | PubMed |
| Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization. | Photodiagnosis Photodyn Ther | 2022 | 35149260 | PubTator, text mining | PubMed |
| Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection. | Sci Rep | 2022 | 35145162 | PubTator, text mining | PubMed |
| Gene expression profiling improves prognostication by nomogram in patients with soft-tissue sarcomas. | Cancer Commun (Lond) | 2022 | 35132812 | PubTator, text mining | PubMed |
| Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals. | J Intern Med | 2022 | 35112415 | PubTator, text mining | PubMed |
| The Perspective of DMPK on Recombinant Adeno-Associated Virus-Based Gene Therapy: Past Learning, Current Support, and Future Contribution. | AAPS J | 2022 | 35102450 | PubTator, text mining | PubMed |
| Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report. | World J Transplant | 2022 | 35096552 | PubTator, text mining | PubMed |
| Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection. | Methods Mol Biol | 2022 | 35094360 | PubTator, text mining | PubMed |
| Genetic causes of acute encephalopathy in adults: beyond inherited metabolic and epileptic disorders. | Neurol Sci | 2022 | 35066645 | PubTator, text mining | PubMed |
| Analysis of Factors Affecting 5-ALA Fluorescence Intensity in Visualizing Glial Tumor Cells-Literature Review. | Int J Mol Sci | 2022 | 35055109 | PubTator, text mining | PubMed |
| Gold (III) Derivatives in Colon Cancer Treatment. | Int J Mol Sci | 2022 | 35054907 | PubTator, text mining | PubMed |
| Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders. | Biomedicines | 2022 | 35052837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=29